I'll be speaking next week in Canberra at #ANZGOG (Australia & NZ Gynaecological Oncology Group), weaving my group's thoughts together on some of the most difficult to treat #ovariancancers and #endometriosis with focus on #ChromatinRemodelling. #OvarianClearCellCarcinoma #SCCOHT #SWI/SNF #ARID1A 🧪

Really enjoying the Australia New Zealand Gynaecological Oncology Group (ANZGOG) Annual Scientific Meeting. Great to connect with super collaborator Gwo Yaw Ho as well! #ANZGOG2025ASM #ovariancancer #ATX

The Australia New Zealand Gynaecological Oncology Group, #ANZGOG, Annual Scientific Meeting will be held in Canberra, Australia, March 5-7, 2025. Abstracts currently due by Dec 2nd. www.anzgogasm.org.au #GynaecologicalCancer #OvarianCancer #EndometrialCancer #BasicScience #ClinicalTrials

Brilliant talk by my colleague Dr Dongli Liu from UNSW at ANZGOG (Australia New Zealand Gynaecological Oncology Group) on the Gold Coast this week. All about development of organoids from patients with ovarian and endometrial cancer & their value in drug testing. #organoids #tumoroids #ANZGOGASM2026

Spoken by women who walk in the shoes - "Underfunding in gynaecological cancer research is costing women their lives". www.womencan.org.au/underfunded #gynaecancer #uterinecancer #endometrialcancer #ovariancancer #cervicalcancer #vaginalcancer #vulvarcancer www.youtube.com/watch?v=gYwC...

Today kicks off a major campaign by ANZGOG to highlight how common and impactful gynecological cancers are, even though each type individually is rare. #oncosky #cansky www.abc.net.au/news/2025-04...

Our CEO Susan Goode & TROG managers had a great catch up with other Collaborative Cancer Trial Group leaders this week, as we work together to #fightcancer.
Thanks @gicancertrials.bsky.social CEO Joanne Cory & ANZGOG CEO Alison Evans for spending some time with us in Newcastle.
www.trog.com.au

Very pleased that Amplia could support the poster session at the ANZGOG 2025 scientific meeting. #ATX #ovariancancer

Amplia Therapeutics is launching a new clinical trial of its protein inhibitor drug narmafotinib in ovarian cancer, partnering with research group ANZGOG. #business #companies

📢 Amplia Therapeutics is launching a new clinical trial of its protein inhibitor drug narmafotinib in ovarian cancer, partnering with research group ANZGOG.

📢 Amplia Therapeutics is launching a new clinical trial of its protein inhibitor drug narmafotinib in ovarian cancer, partnering with research group ANZGOG.

Feed: "Small Caps"
By: Isla Campbell on Friday, May 8, 2026

CONFRONTING PICTURE OF GROWING WOMEN’S HEALTH CRISIS IN UTERINE CANCERS. ANZGOG State of the Nation report highlights inequities in uterine cancer outcomes, With Assoc Prof Yoland Antill, Director and Deputy Chair,Australia New Zealand Gynaecological Oncology Group (ANZGOG) youtu.be/f_wG-PTKjCM

IMPERATIVE NEED TO IMPROVE OUTCOMES FOR WOMEN DIAGNOSED WITH OVARIAN CANCER. Late diagnosis, limited treatment options and significantly low survival rates by Prof Clare Scott, Chair ANZGOG, WEHI @wehi-research.bsky.social & Peter Mac Cancer Centre @petermaccc.bsky.social youtu.be/WBew0dsUMQ0